Lualhati, Agustina J.

HRN: 28-03-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/19/2026
03/26/2026
IV
4.5
Q8H
COMPLICATED UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: